News

Applied Clinical Trials Online2h

FDA Issues Complete Response Letter to Replimune for RP1 Combination Therapy in Advanced Melanoma

The FDA’s complete response letter cited concerns that the Phase I/II IGNYTE (CT03767348) trial in advanced melanoma was not ...
Applied Clinical Trials Online9h

What Clinical Researchers Need to Know About Global Obesity Drug Development

Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, discusses the importance ...